Abstract
BackgroundThe prospective, randomized, controlled MAINRITSAN trial compared rituximab (RTX) to azathioprine (AZA) to maintain ANCA-associated vasculitis (AAV) remission. Once remission was obtained with a conventional regimen, patients were randomly assigned...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have